Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System

Introduction Carbamazepine (CBZ) is a commonly used antiseizures medications (ASM), but its adverse drug reactions (ADRs) can impact the successful management of epilepsy. There are currently limited systematic studies on ADRs related to CBZ, necessitating further investigation.